Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001076809-25-000144·Astria Therapeutics, Inc.
Schedule 13G ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 04635X102
Event date: 2025-12-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Glazer Capital, LLC
Shares: 3,155,200.00 · Class: 5.53%
- Paul J. Glazer
Shares: 3,155,200.00 · Class: 5.53%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001076809-25-000144
- Form type
- SCHEDULE 13G
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Dec 10, 2025
- Reporting period
- Dec 03, 2025
- Description
- Schedule 13G beneficial ownership